TSLA
Tesla
-- 379.280 NVDA
NVIDIA
-- 138.310 RGTI
Rigetti Computing
-- 20.0000 PLTR
Palantir
-- 75.190 AMD
Advanced Micro Devices
-- 120.630 
China Regenerative Medicine International's low P/S ratio ma...
China Regenerative Medicine International's low P/S ratio may be due to its disappointing revenue performance and the expectation of this trend continuing. Its revenue growth falls short of the industry's one-year growth forecast of 79%, which may explain its lower P/S ratio compared to industry peers. The low P/S ratio could continue to impact the share price unless medium-term conditions improve.
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 25% Pounding
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment